Author
Listed:
- Barbara Lovrecic
(National Institute of Public Health, 1000 Ljubljana, Slovenia)
- Mercedes Lovrecic
(National Institute of Public Health, 1000 Ljubljana, Slovenia
Centre for Psychiatry and Addiction Medicine, Izola Health Centre, 6310 Izola, Slovenia)
- Branko Gabrovec
(National Institute of Public Health, 1000 Ljubljana, Slovenia)
- Marco Carli
(Department of Translational Research and New Technologies, University of Pisa, 56100 Pisa, Italy)
- Matteo Pacini
(G. De Lisio Institute of Behavioral Sciences, 56100 Pisa, Italy)
- Angelo G. I. Maremmani
(Department of Psychiatry, North-Western Tuscany Region NHS Local Health Unit, Versilia Zone, 55049 Viareggio, Italy
Association for the Application of Neuroscientific Knowledge to Social Aims (AU-CNS), Pietrasanta, 55045 Lucca, Italy)
- Icro Maremmani
(G. De Lisio Institute of Behavioral Sciences, 56100 Pisa, Italy
Association for the Application of Neuroscientific Knowledge to Social Aims (AU-CNS), Pietrasanta, 55045 Lucca, Italy
Vincent P. Dole Dual Disorder Unit, Santa Chiara University Hospital, University of Pisa, 56100 Pisa, Italy)
Abstract
Background : In the last decade there has been a progressive increase in the use of new psychoactive substances (NPSs) that are not yet under international control. In particular, novel synthetic opioids (NSOs) have reappeared on the recreational drug market in the last few years. As a result, the use of NSOs has increased rapidly. This poses an emerging and demanding challenge to public health. Aim : To raise awareness among clinicians and other professionals about NPSs, especially NSOs, to summarize current knowledge about pharmacological properties, forms of NSO on the market, pattern of use, effects and consequences of use. Methods : An electronic search was carried out on the Medline/PubMed and Google Scholar databases to find selected search terms. Results : Some NPSs are already controlled, while others can be legally sold directly on the drug market (mainly via internet, less so by drug dealers) or be used as precursors for the synthesis of other designer drugs that mimic the psychoactive effects of controlled substances. Potential side-effects of NSOs include miosis, sedation, respiratory depression, hypothermia, inhibition of gastrointestinal propulsion, death (from opioid overdose). Conclusions : The severity of the opioid crisis has intensified with the introduction of highly potent NSOs on the drug market. As long as addicts are dying from overdose or similar causes, there is something more constructive to do than waiting for addicts to overdose on heroin at a place located near a remedy, as if to say, within reach of naloxone.
Suggested Citation
Barbara Lovrecic & Mercedes Lovrecic & Branko Gabrovec & Marco Carli & Matteo Pacini & Angelo G. I. Maremmani & Icro Maremmani, 2019.
"Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health,"
IJERPH, MDPI, vol. 16(2), pages 1-21, January.
Handle:
RePEc:gam:jijerp:v:16:y:2019:i:2:p:177-:d:196267
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:16:y:2019:i:2:p:177-:d:196267. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.